A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Author, public speaker, Olympic torch bearer, and “Cystic Fibrosis Warrior” Andrew Cary Lipman died at age 51 on Jan. 17.

The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

K grant to accelerate development of Glox Therapeutics' novel precision antibiotics targeting AMR lung infections in people ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

Scientists at Caltech and Princeton University have discovered that bacterial cells growing in a solution of polymers, such ...